Physician profile
Philip Griffith
NPI 1255781464
$5,309.83
in general payments reported to CMS, 2019-2025
21 companies · $941 in 2025
The $941 reported for 2025 was more than what 90% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $785 · 2020: $565 · 2021: $1,278 · 2022: $565 · 2023: $485 · 2024: $690 · 2025: $941.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,116.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,116.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $1,198.61 | 2019-2025 | Cequa, Xelpros |
| Allergan, INC. | $762.27 | 2019-2022 | |
| Kala Pharmaceuticals, INC. | $422.14 | 2021-2022 | |
| Alcon Vision LLC | $420.31 | 2022-2025 | Tryptyr, Rocklatan, Clareon |
| Bausch & Lomb Americas INC. | $354.83 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Tarsus Pharmaceuticals, INC. | $333.50 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $283.17 | 2019-2021 | |
| Oyster Point Pharma, INC. | $230.04 | 2022-2025 | Tyrvaya |
| Harrow Eye, LLC | $203.43 | 2024-2025 | Vevye |
| Abbvie INC. | $198.11 | 2022-2025 | |
| Biotissue Holdings INC. | $156.30 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $154.23 | 2021-2022 | |
| Glaukos Corporation | $120.00 | 2021 | |
| Aerie Pharmaceuticals, INC. | $112.92 | 2021 | |
| Dompe US, INC. | $111.30 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $92.02 | 2019-2023 | Misight Contact Lens |
| Rxsight INC | $44.37 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Eyevance Pharmaceuticals LLC | $37.41 | 2019-2022 | |
| Shire North American Group INC | $32.61 | 2019 | |
| Plexus Optix, INC. | $22.10 | 2021 | |
| Thea Pharma INC. | $20.16 | 2024 | Iyuzeh |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philip Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.